Treatment of acute HCV infection in HIV-positive patients: Experience from a multicentre European cohort

Antiviral Therapy

Volumn 15, Issue 2, 2010, Pages 267-273

  Vogel, Martin ^a   Dominguez, Stéphanie ^b   Bhagani, Sanjay ^c   Azwa, Alex ^d   Page, Emma ^d   Guiguet, Marguerite ^e   Volantin, Marc Antoine ^b,e   Katlama, Christine ^b,e   Rockstroh, Jürgen K ^a   Nelson, Mark ^d  

^a UNIVERSITY OF BONN   (Germany)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; BLOOD TOXICITY; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG USE; ENZYME BLOOD LEVEL; EUROPE; EXPERIENCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; VIROLOGY; WEIGHT REDUCTION;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; EUROPE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 77950664980     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1501     Document Type: Article

References (19)

1. Gilleece YC, Browne RE, Asboe D, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin. J Acquir Immune Defic Syndr 2005; 40:41-46. (Pubitemid 41233203)
2. Vogel M, Bieniek B, Jessen H, et al. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat 2005; 12:207-211. (Pubitemid 40342180)
3. Dominguez S, Ghosn J, Valantin MA, et al. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS 2006;20:1157-1161. (Pubitemid 43786104)
4. Gotz HM, van Doornum G, Niesters HG, den Hollander JG, Thio HB, de Zwart O. A cluster of acute hepatitis C virus infection among men who have sex with men - results from contact tracing and public health implications. AIDS 2005; 19:969-974.
5. van de Laar TJ, van der Bij AK, Prins M, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. ; Infect Dis 2007; 196:230-238.
6. Luetkemeyer A, Hare CB, Stansell J, et al. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41:31-36. (Pubitemid 41786016)
7. Matthews GV, Hellard M, Haber P, et al. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in acute hepatitis C. Clin Infect Dis 2009;48:650-658.
8. Giraudon I, Ruf M, Maguire H, et al. Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect 2008; 84:111-115.
9. Jones L, Uriel A, Kaplan D, et al. Natural history and treatment outcome of acute hepatitis C with and without HIV co-infection in a North American cohort. American Association for the Study of Liver Diseases. 31 October-3 November 2008, San Francisco, CA, USA. Abstract 1838.
10. Thomson EC, Nastouli E, Main J, et al. Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV AIDS 2009; 23:89-93.
11. Vogel M, Nattermann J, Baumgarten A, et al. Pegylated interferon-α for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther 2006; 11:1097-1101. (Pubitemid 44955186)
12. Urbanus AT, van de Laar TJ, Stolte IG, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. Aids 2009; 23:F1-F2.
13. Laguno M, Murillas J, Blanco JL, et al. Peginterferon alfa-2b plus ribavirin compared wirh inrerferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 2004; 18:F27-F36. (Pubitemid 39179626)
14. Nunez M, Miralles C, Berdun MA, et al. Role of weightbased ribavirin dosing and exrended durarion of rherapy in chronic hepatitis C in HIV-infecred parienrs: the PRESCO trial. AIDS Res Hum Retroviruses 2007; 23:972-982. (Pubitemid 47492337)
15. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infecrion in HIV-infecred parienrs. N Engl J Med 2004; 351:438-450. (Pubitemid 38988593)
16. Rockstroh JK, Bhagani S, Benhamou Y, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and trearment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008; 9:82-88. (Pubitemid 351228130)
17. Wiegand J, Dererding K, Cornberg M, Wedemeyer H. Treatmenr of acure hepatitis C: the success of monotherapy with (pegylated) inrerferon alpha. J Antimicrob Chemother 2008;62:860-865.
18. +) T-cell response in acure hepatitis C primary infection and reinfection. J Clin Virol 2006; 36:24-31.
19. Wiegand J, Buggisch P, Boecher W, et al. Early monotherapy with pegylated interferon alpha-2b for acure hepatitis C infection: rhe HEP-NET acure-HCV-II srudy. Hepatology 2006; 43:250-256. (Pubitemid 43303993)